Podcast

Knowing Your Hereditary Risk

Author(s):

In this special edition of the CURE Talks Cancer podcast, we kick off National Hereditary Breast and Ovarian Cancer Week and Previvor Day.

In 2010, history was made when a Congressional resolution was passed to declare the first-ever National Hereditary Breast and Ovarian Cancer Week and National Previvor Day to raise awareness about hereditary cancer.

Millions of people carry an inherited mutation or have a family history of cancer but many don't know about their risk. National Hereditary Breast and Ovarian Cancer Week and Previvor Day aim to change that.

In this special edition of the CURE Talks Cancer, we spoke with president and CEO of My Gene Counsel, Ellen Matloff, and founder of Proactive Genes, Shannon Pulaski, to help kick off National Hereditary Breast and Ovarian Cancer Week and Previvor Day. In this episode you’ll hear about their resources and how each can help others learn more about their hereditary risk.

Related Videos
Image of woman with blonde hair.
Image of woman with blonde hair.
Image of woman with brown hair.
a man and a woman in front of a dark blue background
a man and a woman in front of a dark blue background
a man and a woman in separate boxes in front of a dark blue background
Dr. Debu Tripathy discussed the importance of understanding the distinctions between HER2-low and HER2-ultralow breast cancer.
Dr. Debu Tripathy is a professor and chairman of the Department of Breast Medical Oncology, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, in Houston, and the editor-in-chief of CURE®.
Dr. Azka Ali is a medical oncologist at the Cleveland Clinic Taussig Cancer Institute, in Ohio.
Related Content